Sandy Milligan, MD, JD Bio
Sandy Milligan, MD, JD
As Head of Global Regulatory Affairs, Sandy is responsible for the global regulatory strategy and operations necessary to secure the approval and successful launches of new medicines reflecting the quality of our science, meeting unmet medical needs and defining new standards of care across Daiichi Sankyo’s portfolio of medicines.
Sandy brings over two decades of experience in the pharmaceutical and biotechnology sectors, supporting both oncology and non-oncology products, diagnostics, and vaccines. Her focus has been on driving portfolio growth, securing new market approvals, and expanding product lines. Previously, Sandy served as Head of Global Regulatory Affairs, Clinical Safety, and CMC at Merck, where she played a key role in the company's rapid expansion into oncology. She then led Research & Development at Organon. Earlier in her career, Sandy held senior leadership roles in Regulatory Affairs at Genentech and Amgen.
Sandy earned her M.D. from George Washington University and her J.D. from Georgetown University. During her medical training, she served as a General Medical Officer in the US Army.
Sandy is passionate about developing and implementing strategic solutions that drive scientific innovation which improve patient outcomes while navigating the intricate regulatory environment.